GEN Exclusives

More »

GEN News Highlights

Back to Item »

Tioga Raises $10M to Continue Phase III Development of IBS Drug

Ongoing study with asimadoline in D-IBS patients is one of two required for U.S. registration.

Forward this item to a colleague:


(Separate multiple addresses by commas)


(Separate multiple addresses by commas)


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »


Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?